Literature DB >> 25554746

ST2: the biomarker at the heart of GVHD severity.

Sawa Ito1, A John Barrett1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25554746      PMCID： PMC4281822          DOI： 10.1182/blood-2014-11-611780

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.

Authors:  Jennifer E Ho; Wei-Yu Chen; Ming-Huei Chen; Martin G Larson; Elizabeth L McCabe; Susan Cheng; Anahita Ghorbani; Erin Coglianese; Valur Emilsson; Andrew D Johnson; Stefan Walter; Nora Franceschini; Christopher J O'Donnell; Abbas Dehghan; Chen Lu; Daniel Levy; Christopher Newton-Cheh; Honghuang Lin; Janine F Felix; Eric R Schreiter; Ramachandran S Vasan; James L Januzzi; Richard T Lee; Thomas J Wang
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

3.  Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.

Authors:  Fang Yin; Minoo Battiwalla; Sawa Ito; Xingmin Feng; Fariba Chinian; Jan Joseph Melenhorst; Eleftheria Koklanaris; Marianna Sabatino; David Stroncek; Leigh Samsel; Jeffrey Klotz; Nancy F Hensel; Pamela G Robey; A John Barrett
Journal:  Stem Cells       Date:  2014-05       Impact factor: 6.277

Review 4.  Discovery and validation of graft-versus-host disease biomarkers.

Authors:  Sophie Paczesny
Journal:  Blood       Date:  2012-11-19       Impact factor: 22.113

5.  High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.

Authors:  Doris M Ponce; Patrick Hilden; Christen Mumaw; Sean M Devlin; Marissa Lubin; Sergio Giralt; Jenna D Goldberg; Alan Hanash; Katharine Hsu; Robert Jenq; Miguel-Angel Perales; Craig Sauter; Marcel R M van den Brink; James W Young; Renier Brentjens; Nancy A Kernan; Susan E Prockop; Richard J O'Reilly; Andromachi Scaradavou; Sophie Paczesny; Juliet N Barker
Journal:  Blood       Date:  2014-11-06       Impact factor: 22.113

6.  Identification of serum soluble ST2 receptor as a novel heart failure biomarker.

Authors:  Ellen O Weinberg; Masahisa Shimpo; Shelley Hurwitz; Shin-ichi Tominaga; Jean-Lucien Rouleau; Richard T Lee
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

7.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

Authors:  Mark T Vander Lugt; Thomas M Braun; Samir Hanash; Jerome Ritz; Vincent T Ho; Joseph H Antin; Qing Zhang; Chee-Hong Wong; Hong Wang; Alice Chin; Aurélie Gomez; Andrew C Harris; John E Levine; Sung W Choi; Daniel Couriel; Pavan Reddy; James L M Ferrara; Sophie Paczesny
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245

8.  Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Authors:  Erin Gatza; Thomas Braun; John E Levine; James L M Ferrara; Shuang Zhao; Tianyi Wang; Lawrence Chang; Andrew Harris; Attaphol Pawarode; Carrie Kitko; John M Magenau; Gregory A Yanik; Daniel R Couriel; Steven Goldstein; James Connelly; Pavan Reddy; Sophie Paczesny; Sung Won Choi
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-02       Impact factor: 5.742

9.  Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes.

Authors:  Lawrence Chang; David Frame; Thomas Braun; Erin Gatza; David A Hanauer; Shuang Zhao; John M Magenau; Kathryn Schultz; Hemasri Tokala; James L M Ferrara; John E Levine; Pavan Reddy; Sophie Paczesny; Sung Won Choi
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-02       Impact factor: 5.742

10.  IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.

Authors:  Shoji Sanada; Daihiko Hakuno; Luke J Higgins; Eric R Schreiter; Andrew N J McKenzie; Richard T Lee
Journal:  J Clin Invest       Date:  2007-05-10       Impact factor: 14.808
  10 in total
  7 in total

1.  Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.

Authors:  George B McDonald; Laura Tabellini; Barry E Storer; Paul J Martin; Richard L Lawler; Steven L Rosinski; H Gary Schoch; John A Hansen
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-03       Impact factor: 5.742

Review 2.  The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review.

Authors:  Alaa M Ali; John F DiPersio; Mark A Schroeder
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-05       Impact factor: 5.742

3.  Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD.

Authors:  M Zeisbrich; N Becker; A Benner; A Radujkovic; K Schmitt; J Beimler; A D Ho; M Zeier; P Dreger; T Luft
Journal:  Bone Marrow Transplant       Date:  2017-06-26       Impact factor: 5.483

4.  Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution.

Authors:  Joshua N Kellner; Eveline M Delemarre; Eric Yvon; Stefan Nierkens; Jaap J Boelens; Ian McNiece; Amanda Olson; Yago Nieto; Stefan Ciurea; Uday Popat; Sairah Ahmed; Richard Champlin; Jennifer Ramos; Mitsutaka Nishimoto; Hongbing Ma; Zeng Ke; Peter Thall; Joseph D Khoury; Robert Negrin; Borje Andersson; Simrit Parmar
Journal:  Oncotarget       Date:  2018-11-02

Review 5.  Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading?

Authors:  Xiao-Su Zhao; Xiao-Jun Huang
Journal:  Biomark Res       Date:  2019-08-07

Review 6.  Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD).

Authors:  Matthew Mankarious; Nick C Matthews; John A Snowden; Arun Alfred
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

7.  A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.

Authors:  Sendhilnathan Ramalingam; Sharareh Siamakpour-Reihani; Lauren Bohannan; Yi Ren; Alexander Sibley; Jeff Sheng; Li Ma; Andrew B Nixon; Jing Lyu; Daniel C Parker; James Bain; Michael Muehlbauer; Olga Ilkayeva; Virginia Byers Kraus; Janet L Huebner; Thomas Spitzer; Jami Brown; Jonathan U Peled; Marcel van den Brink; Antonio Gomes; Taewoong Choi; Cristina Gasparetto; Mitchell Horwitz; Gwynn Long; Richard Lopez; David Rizzieri; Stefanie Sarantopoulos; Nelson Chao; Anthony D Sung
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.